Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
02/2012
02/16/2012US20120042401 Method for introducing mutant gene, gene having mutation introduced therein, cassette for introducing mutation, vector for introducing mutation, and knock-in non-human mammalian animal
02/16/2012US20120042400 Rtd receptor
02/16/2012US20120042399 Immunogenic peptides
02/16/2012US20120041218 Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
02/16/2012US20120041176 Ucp4
02/16/2012US20120041171 Process for the production of a recombinant polypeptide of interest
02/16/2012US20120041053 DELIVERY OF dsRNA TO ARTHROPODS
02/16/2012US20120041052 Compositions and Methods to Treat Muscular & Cardiovascular Disorders
02/16/2012US20120041051 Compositions And Methods For Inhibiting Expression Of MIG-12 Gene
02/16/2012US20120041050 Antisense oligonucleotides for inducing exon skipping and methods of use thereof
02/16/2012US20120040917 Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of Disease
02/16/2012US20120040909 Identification of novel antagonist toxins of t-type calcium channel for analgesic purposes
02/16/2012US20120040891 Hiv fusion inhibitor peptides with improved biological properties
02/16/2012US20120040862 Method for detecting and quantifying endogenous wheat dna sequence
02/16/2012US20120040851 miRNA TARGETS
02/16/2012US20120040829 Bacterial ghosts as carrier and targeting vehicles
02/16/2012US20120040465 Modification of the genome of a lytic bacteriophage by immobilizing said bacteriophage in the host bacterium thereof
02/16/2012US20120040464 Method for generating homoplasmic cells from heteroplasmic cells
02/16/2012US20120040459 Reduced size self-delivering rnai compounds
02/16/2012US20120040456 Methods of gene therapy using nucleic acid sequences for atp-binding cassette transporter
02/16/2012US20120040452 Glypican-3 (gpc3)-derived tumor rejection antigenic peptides useful for hla-a2-positive patients and pharmaceutical comprising the same
02/16/2012US20120040451 Molecules able to modulate the expression of at least a gene involved in degradative pathways and uses thereof
02/16/2012US20120040436 type milk-clotting protease derived from a microorganism
02/16/2012US20120040435 Novel Variant Hypocrea Jecorina CBH2 Cellulases
02/16/2012US20120040434 Protein exhibiting activity of pyrethrin biosynthetic enzyme, gene encoding the protein, and vector bearing the gene
02/16/2012US20120040433 Live, oral vaccine for protection against shigella dysenteriae serotype 1
02/16/2012US20120040417 Hydroxynitrile lyase
02/16/2012US20120040416 Novel aldolase and production process of substituted alpha-keto acids
02/16/2012US20120040409 Heterologous Biomass Degrading Enzyme Expression in Thermoanaerobacterium Saccharolyticum
02/16/2012US20120040407 Cellobiose 2-epimerase, its preparation and uses
02/16/2012US20120040403 Diguanylate cyclase method of producing the same and its use in the manufacture of cyclic-di-gmp and analogues thereof
02/16/2012US20120040402 Plasmid system for multigene expression
02/16/2012US20120040401 Method For Producing Proteins
02/16/2012US20120040400 Novel Permanent Human Cell Line
02/16/2012US20120040399 Method for the production of recombinant polyomaviral vector particles
02/16/2012US20120040368 Mutated voltage-gated sodium channel nav alpha subunit for identification of modulators
02/16/2012US20120040366 Compositions, methods and uses for disease diagnosis
02/16/2012US20120040365 New competence stimulating peptide
02/16/2012US20120040363 Method for enriching a prokaryotic dna
02/16/2012US20120039986 Compositions and methods for sirna inhibition of angiopoietin 1 and 2 and their receptor tie2
02/16/2012US20120039938 Composition comprising the polyprotein ns3/ns4 and the polypeptide ns5b of hcv, expression vectors including the corresponding nucleic sequences and their therapeutic use
02/16/2012US20120039936 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
02/16/2012US20120039932 Lentiviral Vectors Pseudotyped with a Sindbis Virus Envelope Glycoprotein
02/16/2012US20120039931 Dna composition encoding an immunogenic vegf receptor peptide and methods of use thereof
02/16/2012US20120039923 Modified HIV-1 Envelope Proteins
02/16/2012US20120039921 Poultry viral materials and methods related thereto
02/16/2012US20120039919 Diabetes diagnostic, prophylactic, and therapeutic compositions and methods
02/16/2012US20120039915 Glioblastoma multiforme-reactive antibodies and methods of use thereof
02/16/2012US20120039914 Methods and compositions for using mhc class ii invariant chain polypeptides as a receptor for macrophage migration inhibitory factor
02/16/2012US20120039905 The Role of p110 delta Signaling in Morbidity and Lung Pathology Induced by Influenza Virus Infection
02/16/2012US20120039904 Anti system asc amino acid transporter 2 (asct2) antibody
02/16/2012US20120039898 Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
02/16/2012US20120039891 Methods for diagnosing cancer and decreasing metastasis by cancer cells
02/16/2012US20120039889 Methods of diagnosing and treating prostate cancer characterized by ndrg1-erg fusion
02/16/2012US20120039880 FRAGMENTATION RESISTANT IgG1 Fc-CONJUGATES
02/16/2012US20120039879 Streptavidin having low immunogenicity and use thereof
02/16/2012US20120039877 E1-minus adenoviruses and use thereof
02/16/2012US20120039875 Diagnostic and therapeutic methods and compositions involving pten and breast cancer
02/16/2012US20120039874 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
02/16/2012US20120039858 Methods and compositions for inhibiting propagation of viruses using recombinant tetherin constructs
02/16/2012US20120039807 Anti-Tenascin-C A2 Antibodies and Methods of Use
02/16/2012US20120039806 Compounds and Methods for Modulating an Immune Response
02/16/2012DE102004045186B9 Liposomen, die die intrazelluläre Penetration von Wirkstoffen stimulieren, deren Verwendung zur Herstellung von topischen pharmazeutischen bzw. kosmetischen Zusammensetzungen, die diese Liposomen enthalten sowie ein Screening-Verfahren zum Auffinden von Substanzen zur Stimulierung der intrazellulären Penetration Liposomes, which stimulate the intracellular penetration of active substances, their use for the preparation of topical pharmaceutical and cosmetic compositions containing these liposomes as well as a screening method for finding substances for stimulating the intracellular penetration
02/16/2012CA2845280A1 Therapeutic uses of microvesicles and related micrornas
02/16/2012CA2808044A1 Isopropyl alcohol-producing bacterium having improved productivity by gntr destruction
02/16/2012CA2807891A1 Polymer particle
02/16/2012CA2807858A1 Injectable pharmaceutical composition for preventing, stabilising and/or inhibiting pathological neovascularization-related conditions
02/16/2012CA2807628A1 Methods and pharmaceutical compositions for the treatment of an ocular disease in a subject
02/16/2012CA2807616A1 Methods and compositions for preventing a condition
02/16/2012CA2807587A1 Fluorescent proteins with increased activity in cells
02/16/2012CA2807544A1 Process of transfecting plants
02/16/2012CA2805941A1 Methods and compositions for targeting sequences of interest to the chloroplast
02/16/2012CA2805937A1 Chimeric promoters and methods of use
02/16/2012CA2805803A1 Compositions and methods comprising sequences having hydroxyphenylpyruvate dioxygenase (hppd) activity
02/16/2012CA2804424A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases
02/16/2012CA2804416A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases
02/16/2012CA2801218A1 Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded protein
02/15/2012EP2418490A1 Tumor marker and use thereof
02/15/2012EP2418289A1 Method of distinguishing genotypes
02/15/2012EP2418284A1 Protein body-inducing polypeptide sequences
02/15/2012EP2418283A1 Process of transfecting plants
02/15/2012EP2418282A2 Method for selecting a high expression recombinant cell line
02/15/2012EP2418281A2 Methods and compositions for delivering polynucleotides
02/15/2012EP2418280A1 Compositions and methods for monitoring and altering protein folding and solubility
02/15/2012EP2418279A1 Injectable pharmaceutical composition for preventing, stabilising and/or inhibiting pathological neovascularization-related conditions
02/15/2012EP2418278A2 Human monoclonal antibodies to programmed death 1(PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
02/15/2012EP2418277A1 Method for culturing microorganism, and process for producing substance with microorganism
02/15/2012EP2418276A1 Microorganism strain for producing recombinant proteins
02/15/2012EP2418275A1 Strains of s.cerevisiae, capable of growing in media with melibiose, stachyose and raffinose
02/15/2012EP2418274A2 Multimeric Oxidoreductases
02/15/2012EP2418215A1 Rice zinc finger protein transcription factor dst and use thereof for regulating drought and salt tolerance
02/15/2012EP2418212A1 Isolation of five novel genes coding for new fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma
02/15/2012EP2418018A2 Methods for the separation nucleic acids
02/15/2012EP2417985A1 Mitochondrial function-improving agent
02/15/2012EP2417984A1 Method for treatment of blood tumor using anti-tim-3 antibody
02/15/2012EP2417270A2 Digital quantification of dna methylation
02/15/2012EP2417263A1 Production of proteins using transposon-based vectors
02/15/2012EP2417262A1 Nanoparticle mediated delivery of sequence specific nucleases
02/15/2012EP2417261A1 Markers associated with soybean rust resistance and methods of use therefor
02/15/2012EP2417260A1 A genetically stable plasmid expressing pdh and fdh enzymes
1 ... 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 ... 4023